Reference | Peptide useda | Citrullination sites | Fibrinogen chain | Percentage of reactive sera (%) |
---|---|---|---|---|
Sebbag et al. [4]. | ___________R D R QHLPLIKMKPVP | 216, 218 | α | 0 |
_________LPS R D R QHLPLIKMK | 216, 218 | α | 0 | |
Perez et al. [9]. | ____IAKDLLPS R DRQHLPLIK | 216 | α | 18 |
____IAKDLLPSRD R QHLPLIK | 218 | α | 0 | |
____IAKDLLPS R D R QHLPLIK | 216, 218 | α | 0 | |
Sebbag et al. [4]. | _____________SSHHPGIAEFP R GK | 573 | α | 25 |
Kubota et al. [15]. | ___SGIFTNTKESSSHHPGIAEFP R GKSSSY | 573 | α | n.d. |
Nakayama-Hamada et al. [16]. | b) | 573 | α | n.d. |
Sebbag et al. [4]. | _____________R GDSTFESKSYKMAD | 591 | α | 0 |
__________SYN R GDSTFESKSYK | 591 | α | 20 | |
Kubota et al. [15]. | ____QFTSSTSYN R GDSTFESKS | 591 | α | n.d. |
Nakayama-Hamada et al. [16]. | b) | 591 | α | n.d. |
Perez et al. [9]. | A R GH R PLDKK R EEAPSL R PA | 44, 47, 53, 60 | β | 3 |
ARGH R PLDKK R EEAPSL R PA | 47, 53, 60 | β | 9 | |
A R GHRPLDKK R EEAPSL R PA | 44, 53, 60 | β | 6 | |
Sebbag et al. [4]. | _______DKK R EEAPSL R PAPP | 53,60 | β | 0 |
Perez et al. [9]. | ARGHRPLDKK R EEAPSL R PA | 53,60 | β | 12 |
ARGHRPLDKKREEAPSL R PA | 60 | β | 12 | |
A R GHRPLDKKREEAPSL R PA | 44, 60 | β | 0 | |
ARGH R PLDKKREEAPSL R PA | 47, 60 | β | 36 | |
A R GH R PLDKKREEAPSL R PA | 44, 47, 60 | β | 12 | |
______________R ARPAKAAATQKKVERKA | 72 | β | 0 | |
______________RA R PAKAAATQKKVERKA | 74 | β | 0 | |
Sebbag et al. [4]. | __R PAPPPISGGGY R A R | 60, 72, 74 | β | 28 |
Hill et al. [7]. | ___________GGY R A R PAKAAAT | 72, 74 | β | 0 |
Perez et al. [9]. | _____________R A R PAKAAATQKKVERKA | 72, 74 | β | 0 |
Nakayama-Hamada et al. [16]. | b) | 53, 60, 72, 74 | β | n.d. |
Perez et al. [9]. | _____________R ARPAKAAATQKKVE R KA | 72, 87 | β | 0 |
_____________RA R PAKAAATQKKVE R KA | 74, 87 | β | 0 | |
_____________R A R PAKAAATQKKVE R KA | 72, 74, 87 | β | 0 |